TRAF2 inhibits senescence in hepatocellular carcinoma cells via regulating the ROMO1/ [PMID: 38043870] Laboratory literature summary: TRAF2 inhibits senescence in hepatocellular carcinoma cells via regulating the ROMO1/ NAD(+)/SIRT3/SOD2 axis
Bottom Line : The FDA hasnt approved it for anything specific, but glutathione IV therapy looks promising for certain health problems, though many wellness claims dont have solid proof yet
doi: 10.1093/milmed/usaa288 Loss of NRF2 accelerates cognitive decline, exacerbates mitochondrial dysfunction, and is required for the cognitive enhancing effects of Centella asiatica during aging Zweig JA et al
Introduction Finding the right balance in a wellness routine can feel like a complex puzzle
If any redness, burning, itching, blistering or irritation is observed at any time throughout the test, do not use the product
As an interdisciplinary cutting-edge field, DDS relies on the precise design of nanocarriers to achieve spatiotemporally controlled drug delivery [14]